| Title |
Sertindole versus other atypical antipsychotics for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2009
|
| DOI | 10.1002/14651858.cd006752.pub2 |
| Pubmed ID | |
| Authors |
Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Sandra Schwarz, Franziska Schmid, Ruth Lewis, Werner Kissling, Stefan Leucht |
| Abstract |
In many countries of the industrialised world second generation (atypical) antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether and, if so, how much the effects of the various second generation antipsychotics differ is a matter of debate. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Finland | 1 | 20% |
| United Kingdom | 1 | 20% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Chile | 1 | <1% |
| Unknown | 142 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 20 | 14% |
| Researcher | 19 | 13% |
| Student > Master | 18 | 13% |
| Student > Doctoral Student | 14 | 10% |
| Other | 12 | 8% |
| Other | 28 | 19% |
| Unknown | 33 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 60 | 42% |
| Psychology | 17 | 12% |
| Nursing and Health Professions | 11 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 12 | 8% |
| Unknown | 35 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2017.
All research outputs
#7,882,399
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#8,726
of 11,499 outputs
Outputs of similar age
#36,220
of 107,207 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 64 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,207 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.